Cargando…
Critical appraisal of pazopanib as treatment for patients with advanced metastatic renal cell carcinoma
The management of renal cell carcinoma (RCC) has undergone significant changes during the past 10 years, with the treatment of metastatic RCC undergoing the most radical changes. These developments reflect an enhanced understanding of this tumor’s underlying biology, which was then translated into t...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173017/ https://www.ncbi.nlm.nih.gov/pubmed/21931501 http://dx.doi.org/10.2147/CMR.S15557 |